N-acetyl-cysteine (NAC) and Kidney Graft Function

• Status: Completed
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to evaluate the effect of N-acetyl-cysteine (NAC) administration in organ donors on the kidney graft function of recipients.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut d'Anesthesiologie des Alpes Maritimes
• Treatments: Acetylcysteine; N-monoacetylcystine

Criteria

Inclusion Criteria:

• all recipient for kidney graft in our hospital

Exclusion Criteria:

• transplantation out side our hospital

• refusal from the patient